Drug Discovery

The ongoing escalation of antimicrobial resistance has effectively pushed modern medicine toward a precipice where common infections could once again become untreatable without a fundamental shift in drug discovery. This looming crisis is particularly evident in the treatment of Neisseria

The global pharmaceutical sector is currently undergoing a massive transformation as the industry faces the dual challenges of rising research costs and the diminishing returns of traditional screening methods. Innovations in artificial intelligence and robotics are no longer merely speculative

The traditional pharmaceutical development funnel is currently facing a massive overhaul as researchers move away from static, isolated chemical assays toward dynamic platforms that observe drug behavior within the bustling complexity of living human cells. This transition marks a fundamental

The persistent struggle to eradicate aggressive malignant tumors often hinges on the cellular ability to withstand the intense biological stress inflicted by conventional therapeutic interventions like radiation. For decades, oncologists identified the insulin-like growth factor 1 receptor,

The conventional diagnostic approach of treating a tumor as a uniform mass of malignant cells has reached a functional ceiling in oncology, necessitating a move toward high-resolution architectural mapping. The Spatial Transcriptomic Tumor Atlas represents a pivotal shift in this landscape, moving

The quest to understand how malignant cells detach from a primary tumor and successfully colonize distant organs has long remained one of the most formidable challenges in modern oncology. While traditional therapies often succeed in shrinking localized masses, the ability of certain cells to evade